596.4500 -5.95 (-0.99%)
NSE Oct 23, 2026 15:31 PM
Volume: 148.1K
 

596.45
-0.99%
Axis Direct
We initiate coverage on the company with a BUY rating on the stock with a target price of Rs 1,730/share, based on a multiple of 56x P/E for FY28E. The TP implies an upside potential of 20% from the CMP.
Number of FII/FPI investors increased from 44 to 59 in Sep 2026 qtr.
More from Nephrocare Health Services Ltd.
Recommended